\-\ Texto\\:\\ \ \(0\)\
\-\ \\*markedly\\ ataxic\\ gait\\.\\ \\ \ \(0\)\
\-\ \\*abnormal\\ mini\\-mental\\ status\\ exam\\ score\\ of\\ 22\\/30\\.\ \(0\)\
\-\ the\\ patient\\ underwent\\ csf\\ shunting\\,\\ which\\ resulted\\ in\\ a\\ mild\\ improvement\\ in\\ symptoms\\.\ \(0\)\
\-\ axial\\ ct\\ images\\ through\\ the\\ brain\\ show\\ communicating\\ hydrocephalus\\,\\ with\\ dilatation\\ of\\ the\\ third\\ ventricle\\ and\\ lateral\\ ventricles\\ in\\ the\\ absence\\ of\\ significant\\ co\\-existent\\ sulcal\\ enlargement\\.\\ \\ also\\ noted\\ were\\ prominent\\ temporal\\ horns\\ \\(not\\ shown\\)\\.\ \(0\)\
\-\ normal\\ pressure\\ hydrocephalus\\ \\(nph\\)\ \(0\)\
\-\ a\\ normal\\ opening\\ pressure\\ at\\ lumbar\\ puncture\\,\\ in\\ combination\\ with\\ the\\ previously\\ described\\ imaging\\ findings\\,\\ confirmed\\ the\\ diagnosis\\ of\\ normal\\ pressure\\ hydrocephalus\\.\ \(0\)\
\-\ a\\ 76\\-year\\-old\\ african\\ american\\ male\\ with\\ end\\ stage\\ renal\\ disease\\,\\ hypertension\\,\\ hyperlipidemia\\,\\ and\\ hypothyroidism\\,\\ now\\ presenting\\ with\\ a\\ 2\\-3\\ month\\ history\\ of\\ mental\\ status\\ changes\\,\\ ataxia\\,\\ and\\ urinary\\ incontinence\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.08164121927697418\ \(0\)\
\-\ pressure\\:\\ 0\\.07457628688494088\ \(0\)\
\-\ \\*\\:\\ 0\\.07044556168029747\ \(0\)\
\-\ 22\\/30\\:\\ 0\\.06530013647382592\ \(0\)\
\-\ mini\\-mental\\:\\ 0\\.060165712914122614\ \(0\)\
\-\ 76\\-year\\-old\\:\\ 0\\.060165712914122614\ \(0\)\
\-\ co\\-existent\\:\\ 0\\.05503128935441932\ \(0\)\
\-\ nph\\:\\ 0\\.05503128935441932\ \(0\)\
\-\ ataxic\\:\\ 0\\.04902439886392799\ \(0\)\
\-\ sulcal\\:\\ 0\\.046300511603740456\ \(0\)\
\-\ status\\:\\ 0\\.04519003438787635\ \(0\)\
\-\ score\\:\\ 0\\.040886530058979034\ \(0\)\
\-\ shunting\\:\\ 0\\.04035720439985203\ \(0\)\
\-\ horns\\:\\ 0\\.03986319421838039\ \(0\)\
\-\ opening\\:\\ 0\\.03917894740259509\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.03917894740259509\ \(0\)\
\-\ puncture\\:\\ 0\\.038964224907237666\ \(0\)\
\-\ communicating\\:\\ 0\\.03855259638016499\ \(0\)\
\-\ incontinence\\:\\ 0\\.03743939487609582\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.037102636549601324\ \(0\)\
\-\ resulted\\:\\ 0\\.03575210649927573\ \(0\)\
\-\ 2\\-3\\:\\ 0\\.03415426521907802\ \(0\)\
\-\ ataxia\\:\\ 0\\.03382980134753436\ \(0\)\
\-\ african\\:\\ 0\\.0330282192390882\ \(0\)\
\-\ end\\:\\ 0\\.03213467858880216\ \(0\)\
\-\ combination\\:\\ 0\\.03188636235147888\ \(0\)\
\-\ american\\:\\ 0\\.03015249107854258\ \(0\)\
\-\ markedly\\:\\ 0\\.029961731848154323\ \(0\)\
\-\ ventricles\\:\\ 0\\.029775762061998202\ \(0\)\
\-\ normal\\:\\ 0\\.029769165657757803\ \(0\)\
\-\ improvement\\:\\ 0\\.029534849530845907\ \(0\)\
\-\ mental\\:\\ 0\\.029534849530845907\ \(0\)\
\-\ gait\\:\\ 0\\.029475826051963114\ \(0\)\
\-\ urinary\\:\\ 0\\.02930152607114686\ \(0\)\
\-\ dilatation\\:\\ 0\\.027127606144212734\ \(0\)\
\-\ stage\\:\\ 0\\.027000255029098863\ \(0\)\
\-\ described\\:\\ 0\\.026958286602908662\ \(0\)\
\-\ lumbar\\:\\ 0\\.02691655461981047\ \(0\)\
\-\ previously\\:\\ 0\\.026590901853728127\ \(0\)\
\-\ csf\\:\\ 0\\.02643329149485935\ \(0\)\
\-\ absence\\:\\ 0\\.026317246185641577\ \(0\)\
\-\ prominent\\:\\ 0\\.025979635011594764\ \(0\)\
\-\ presenting\\:\\ 0\\.025798515782971328\ \(0\)\
\-\ third\\:\\ 0\\.025381086623333316\ \(0\)\
\-\ shown\\:\\ 0\\.025381086623333316\ \(0\)\
\-\ temporal\\:\\ 0\\.025347339834178792\ \(0\)\
\-\ enlargement\\:\\ 0\\.025115321529519227\ \(0\)\
\-\ hypertension\\:\\ 0\\.024953933720742134\ \(0\)\
\-\ confirmed\\:\\ 0\\.023802960022865166\ \(0\)\
\-\ ventricle\\:\\ 0\\.023721409759840207\ \(0\)\
\-\ underwent\\:\\ 0\\.021719970633171996\ \(0\)\
\-\ now\\:\\ 0\\.02163789325704924\ \(0\)\
\-\ \\,\\:\\ 0\\.02005259744572499\ \(0\)\
\-\ show\\:\\ 0\\.01943078469993797\ \(0\)\
\-\ brain\\:\\ 0\\.0190470483207612\ \(0\)\
\-\ renal\\:\\ 0\\.019018337403393107\ \(0\)\
\-\ month\\:\\ 0\\.018989737339263773\ \(0\)\
\-\ changes\\:\\ 0\\.018141096120259707\ \(0\)\
\-\ axial\\:\\ 0\\.018065122044947198\ \(0\)\
\-\ abnormal\\:\\ 0\\.018052535113443787\ \(0\)\
\-\ through\\:\\ 0\\.01797745939571014\ \(0\)\
\-\ significant\\:\\ 0\\.01702109000780906\ \(0\)\
\-\ mild\\:\\ 0\\.016668544103193607\ \(0\)\
\-\ symptoms\\:\\ 0\\.015775240569615847\ \(0\)\
\-\ noted\\:\\ 0\\.015003119914463658\ \(0\)\
\-\ imaging\\:\\ 0\\.014830176477448909\ \(0\)\
\-\ diagnosis\\:\\ 0\\.014534958005780889\ \(0\)\
\-\ were\\:\\ 0\\.014372491382888306\ \(0\)\
\-\ exam\\:\\ 0\\.013905436592218802\ \(0\)\
\-\ lateral\\:\\ 0\\.013679022560181855\ \(0\)\
\-\ findings\\:\\ 0\\.013472866191036739\ \(0\)\
\-\ in\\:\\ 0\\.012485843856007555\ \(0\)\
\-\ also\\:\\ 0\\.012478663656815936\ \(0\)\
\-\ images\\:\\ 0\\.012142695495921141\ \(0\)\
\-\ which\\:\\ 0\\.011815885831426287\ \(0\)\
\-\ a\\:\\ 0\\.011751105239069668\ \(0\)\
\-\ male\\:\\ 0\\.011445966947314616\ \(0\)\
\-\ \\(\\:\\ 0\\.010701655203612749\ \(0\)\
\-\ \\)\\:\\ 0\\.010570928772048965\ \(0\)\
\-\ disease\\:\\ 0\\.010346204009005216\ \(0\)\
\-\ not\\:\\ 0\\.009146804975866188\ \(0\)\
\-\ ct\\:\\ 0\\.008854101136237356\ \(0\)\
\-\ history\\:\\ 0\\.008742329908941358\ \(0\)\
\-\ at\\:\\ 0\\.008576023354308394\ \(0\)\
\-\ patient\\:\\ 0\\.006345125414195467\ \(0\)\
\-\ the\\:\\ 0\\.00614441265349448\ \(0\)\
\-\ of\\:\\ 0\\.004314955585110683\ \(0\)\
\-\ and\\:\\ 0\\.004000200127382633\ \(0\)\
\-\ with\\:\\ 0\\.0034667904026633996\ \(0\)\
\-\ \\.\\:\\ 0\\.001840716686529066\ \(0\)\
